OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.430
+0.015 (1.06%)
At close: Oct 15, 2026, 4:00 PM EDT
1.430
0.00 (0.00%)
After-hours: Oct 15, 2026, 4:00 PM EDT
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $75.05 million as of October 15, 2026. It is the 27,398th most valuable company in the world and the 4,359th biggest in the United States. Its market cap has increased by 2.32% in one year.
Market Cap
75.05M
Enterprise Value
54.45M
1-Year Change
2.32%
Global Rank
Country Rank
#4,359 United States
Category
ChartMarket Cap Chart
Since the IPO on May 17, 2022, OKYO Pharma's market cap has decreased from $86.61M to $75.05M, a decrease of -13.35%. That is a compound annual growth rate of -3.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 75.05M | -3.61% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -50.99% |
| May 17, 2022 | 86.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 80.24M |
| Nutriband | 79.26M |
| Cardiff Oncology | 78.57M |
| Pelthos Therapeutics | 77.68M |
| ProMIS Neurosciences | 77.66M |
| Cognition Therapeutics | 76.24M |
| Acrivon Therapeutics | 74.99M |
| Heron Therapeutics | 74.16M |